Expression and significance of biglycan in endometrial cancer

Archives of Gynecology and Obstetrics

Volumn 289, Issue 3, 2014, Pages 649-655

  Liu, Yang ^a   Li, Weihua ^a   Li, Xin ^a   Tai, Yanhong ^b   Lü, Qingtao ^c   Yang, Ning ^a   Jiang, Jie ^a  

^a SHANDONG UNIVERSITY   (China)

^b 90th Hospital of Jinan   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Biglycan; Cancerous mesenchyme; Endometrial cancer; Prognosis

Indexed keywords

BIGLYCAN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESENCHYME; PATHOLOGY; PERITONEUM LAVAGE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADULT; AGED; BIGLYCAN; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84896737072     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3017-3     Document Type: Article

References (17)

1. Van der Horst PH, Wang Y, Vandenput I et al (2012) Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer. PLoS One 7(1):e30840
2. Iozzo R (1999) The biology of the small leucine-rich proteoglycans: functional network of interactive proteins [review]. J Biol Chem 274:18843-18846
3. Ameye L, Aria D, Jepsen K et al (2002) Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 16(7):673-680
4. Weber CK, Sommer G, Michl P et al (2001) Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 121(3):657-667
5. Gotte M, Sofeu Feugaing DD, Kresse H (2004) Biglycan is internalized via a chlorpromazine-sensitive route. Cell Mol Biol Lett 9(3):475-481
6. Nishino R, Honda M, Yamashita T et al (2008) Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J Hepatol 49(2):207-216
7. Pan S, Cheng L, White JT et al (2009) Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancers. OMICS 13(4):345-354
8. Modolo F, Biz MT, Martins MT et al (2010) Expression of extracellular matrix proteins in adenomatoid odontogenic tumor. J Oral Pathol Med 39(3):230-235
9. Mikula M, Rubel T, Karczmarski J et al (2010) Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics 11:215-224
10. Wang B, Li GX, Zhang SG et al (2011) Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Exp Biol Med 236(11):1247-1253
11. Yamamoto K, Ohga N, Hida Y et al (2012) Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells. Br J Cancer 106(6):1214-1223
12. Gallagher J (2007) Messages in the matrix: proteoglycans go the distance. Dev Cell 13(2):166-167
13. Gu X, Ma Y, Xiao J et al (2012) Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers. Clin Exp Med 12(3):195-199
14. Wu Z, Aron AW, Macksoud EE et al (2012) Uterine dysfunction in biglycan and decorin deficient mice leads to dystocia during parturition. PLoS One 7(1):e29627
15. Chen WB, Lenschow W, Tiede K et al (2002) Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J Biol Chem 277(39):36118-36128
16. Mikula M, Rubel T, Karczmarski J et al (2010) Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics 11:215-224
17. Galamb O, Sipos F, Spisak S et al (2009) Potential biomarkers of colorectal adenoma-dysplasia carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and downregulated genes. Cell Oncol 31:19-29